The Cold Flu Supplements Industry includes high-dose Vitamin C chewables, immune-boosting botanical syrups, bioavailable zinc capsules, and daily preventative wellness blends built to satisfy rigorous consumer quality standards.
The global Cold Flu Supplements Market Size was valued at US$ 22.80 billion in 2025 and is projected to reach US$ 56.77 billion by 2033, growing at a CAGR of 12.08% during 2026–2033.